Technical Analysis for NXS - Next Science Limited

Grade Last Price % Change Price Change
D 0.310 0.00% 0.000
NXS closed unchanged on Tuesday, April 30, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 3
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Up 2% about 23 hours ago
Up 1% about 23 hours ago
Up 3% about 23 hours ago
Down 1 ATR 2 days ago
Fell Below Previous Day's Low 2 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Next Science Limited Description

Next Science Limited is an Australia-based medical technology company. The Company focuses on the development and commercialization of its Xbio technology to reduce the impact of biofilm-based infections in human health. Its products include Bactisure Surgical Lavage, BlastX Antimicrobial Wound Gel, TorrentX Wound Wash, SurgX Sterile Antimicrobial Wound Gel for Surgical Site Infections and Acne Treatment. The SurgX is a surgical gel designed to help reduce superficial surgical site infections (SSIs) and protect wound tissue to facilitate natural healing. Its Bactisure is designed to remove structurally resistant forms of bacteria (biofilm) through physical deconstruction of the extracellular polymeric substance (EPS) matrix, making bacteria more susceptible to traditional antibiotics and the body’s normal defense mechanisms. BlastX is an antimicrobial wound gel and deconstructs the bacterial biofilm, the gel envelops and eliminates the bacteria.


Classification

Sector: Basic Materials
Industry: Independent Oil & Gas
Keywords: Health Construction Biology Medical Technology Sms Film Infection Bacteria Wound Bacteriology Microbiology Antibiotic Acne Antibiotics Antimicrobial Healing Infections Bio Technology Environmental Microbiology

Is NXS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.745
52 Week Low 0.18
Average Volume 130,504
200-Day Moving Average 0.393
50-Day Moving Average 0.362
20-Day Moving Average 0.363
10-Day Moving Average 0.377
Average True Range 0.028
RSI (14) 39.02
ADX 23.87
+DI 26.364
-DI 34.312
Chandelier Exit (Long, 3 ATRs) 0.388
Chandelier Exit (Short, 3 ATRs) 0.393
Upper Bollinger Bands 0.441
Lower Bollinger Band 0.285
Percent B (%b) 0.16
BandWidth 42.940
MACD Line -0.005
MACD Signal Line 0.004
MACD Histogram -0.0087
Fundamentals Value
Market Cap 60.2 Million
Num Shares 194 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -3.88
Price-to-Sales 55.88
Price-to-Book 12.92
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.325
Resistance 3 (R3) 0.327 0.323 0.323
Resistance 2 (R2) 0.323 0.320 0.323 0.322
Resistance 1 (R1) 0.317 0.317 0.315 0.315 0.321
Pivot Point 0.313 0.313 0.313 0.313 0.313
Support 1 (S1) 0.307 0.310 0.305 0.305 0.299
Support 2 (S2) 0.303 0.307 0.303 0.298
Support 3 (S3) 0.297 0.303 0.298
Support 4 (S4) 0.295